Production (Stage)
Ikena Oncology, Inc.
IKNA
$1.43
$0.064.38%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 95.64M | 114.05M | 124.39M | 138.03M | 145.42M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.37M | 2.95M | 2.78M | 3.50M | 3.90M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 99.01M | 117.00M | 127.17M | 141.53M | 149.32M |
|
|
|||||
| Total Current Assets | 99.01M | 117.00M | 127.17M | 141.53M | 149.32M |
| Net Property, Plant & Equipment | 2.98M | 3.61M | 4.23M | 4.84M | 5.55M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 24.17M | 10.23M | 10.11M | 2.61M | 2.61M |
| Total Assets | 126.17M | 130.84M | 141.51M | 148.99M | 157.49M |
|
|
|||||
| Total Accounts Payable | 512.00K | 805.00K | 897.00K | 1.54M | 1.41M |
| Total Accrued Expenses | 2.94M | 3.96M | 6.07M | 3.73M | 3.02M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.83M | 3.89M | 3.78M | 3.92M | 3.70M |
| Total Finance Division Other Current Liabilities | 39.00K | 140.00K | 23.00K | 47.00K | 69.00K |
| Total Other Current Liabilities | 39.00K | 140.00K | 23.00K | 47.00K | 69.00K |
| Total Current Liabilities | 7.32M | 8.79M | 10.78M | 9.24M | 8.20M |
|
|
|||||
| Total Current Liabilities | 7.32M | 8.79M | 10.78M | 9.24M | 8.20M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.84M | 2.72M | 3.74M | 4.47M | 5.40M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.09M | 1.08M | 1.06M | 1.05M | 1.03M |
| Total Liabilities | 10.26M | 12.59M | 15.58M | 14.76M | 14.63M |
|
|
|||||
| Common Stock & APIC | 458.85M | 458.39M | 457.49M | 456.49M | 455.47M |
| Retained Earnings | -343.01M | -340.24M | -331.62M | -322.50M | -312.26M |
| Treasury Stock & Other | 65.00K | 99.00K | 68.00K | 240.00K | -350.00K |
| Total Common Equity | 115.91M | 118.25M | 125.93M | 134.23M | 142.86M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 115.91M | 118.25M | 125.93M | 134.23M | 142.86M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 115.91M | 118.25M | 125.93M | 134.23M | 142.86M |
|
|
|||||